QNRX - Quoin Pharmaceuticals Ltd. (QNRX) Q4 2023 Earnings Call Transcript
2024-03-14 12:57:03 ET
Quoin Pharmaceuticals, Ltd. (QNRX)
Q4 2023 Earnings Conference Call
March 14, 2024, 8:30 AM ET
Company Participants
Gordon Dunn - Chief Financial Officer
Michael Myers - Chief Executive Officer
Conference Call Participants
Nazibur Rahman - Maxim Group
James Molloy - Alliance Global Partners
Dean Finley - Private Investor
Presentation
Operator
Good day and welcome to the Quoin Pharmaceuticals Fourth Quarter Financial Results and Business Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, today's event is being recorded.
I would now like to turn the conference over to Gordon Dunn, Chief Financial Officer. Please go ahead, sir.
Gordon Dunn
Thank you, and good morning. We appreciate you joining us on today's conference call. With me on the call are Dr. Michael Myers, CEO; and Denise Carter, COO. We're pleased to provide an update on our progress for the fourth quarter of 2023 as well as discussing our Q4 and full year 2023 financial results. Please note that our operations and financial results press release is now available on our website....
Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call Transcript